tiprankstipranks
Trending News
More News >
CanadaBis Capital, Inc. (TSE:CANB)
:CANB
Canadian Market

CanadaBis Capital (CANB) AI Stock Analysis

Compare
13 Followers

Top Page

TSE:CANB

CanadaBis Capital

(CANB)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
C$0.03
▲(45.00% Upside)
The score is held down primarily by deteriorating fundamentals—declining revenue, a swing to net losses, and materially negative operating/free cash flow—paired with a bearish technical setup (below major moving averages and negative MACD). Valuation provides limited support because the negative P/E reflects losses and no dividend yield is available.
Positive Factors
Balanced Portfolio Strategy
Diversifying into technology and health sectors can provide stability and growth opportunities, reducing reliance on the volatile cannabis market.
Strategic Partnerships
Strategic partnerships can lead to new revenue streams and strengthen market presence, providing long-term business growth and resilience.
Market Demand for Cannabis
Sustained demand in the cannabis sector supports revenue growth, providing a stable foundation for the company's investment strategy.
Negative Factors
Declining Revenue
A decline in revenue indicates potential market challenges and could impact future profitability and cash flow, necessitating strategic adjustments.
Negative Cash Flow
Persistent negative cash flow may require external funding, increasing financial risk and potentially affecting the company's long-term viability.
Rising Leverage
Increasing leverage can strain financial flexibility and elevate risk, especially in a challenging revenue environment, impacting long-term stability.

CanadaBis Capital (CANB) vs. iShares MSCI Canada ETF (EWC)

CanadaBis Capital Business Overview & Revenue Model

Company DescriptionCanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through three segments: Cultivation and Wholesale, Retail, and Extraction and Tolling. The Cultivation and Wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. The Retail segment sells cannabis and cannabis related products to end consumers on premise owned and operated by the company. The Extraction and Tolling segment provides cannabinoid extraction services to other licensed producers. CanadaBis Capital Inc. is based in Red Deer, Canada.
How the Company Makes MoneyCanadaBis Capital generates revenue through a combination of equity investments, strategic partnerships, and advisory services. The company invests in cannabis-related businesses, acquiring equity stakes that yield returns through dividends and capital appreciation as these companies grow. Additionally, CanadaBis Capital provides advisory services to its portfolio companies, earning fees for strategic guidance and operational support. Significant partnerships with established industry players enhance its market position and provide access to new revenue opportunities, while ongoing market demand for cannabis products contributes to the financial performance of its investments.

CanadaBis Capital Financial Statement Overview

Summary
CanadaBis Capital faces significant financial challenges, with declining revenues, negative profitability, and cash flow issues. While the company maintains some operational efficiency, as seen in its gross profit margin, the increasing leverage and inability to generate positive cash flows are concerning.
Income Statement
CanadaBis Capital has experienced declining revenue over the past year, with a negative revenue growth rate of -1.52%. The company is currently unprofitable, as indicated by a negative net income and net profit margin. However, the gross profit margin remains relatively healthy, suggesting some operational efficiency. The EBIT and EBITDA margins have decreased significantly compared to previous years, indicating challenges in maintaining profitability.
Balance Sheet
The balance sheet shows a moderate debt-to-equity ratio, which has increased over the past year, indicating rising leverage. The equity ratio is stable, suggesting a balanced asset structure. However, the return on equity has turned negative, reflecting the company's current unprofitability and potential challenges in generating returns for shareholders.
Cash Flow
The cash flow statement reveals negative operating and free cash flows, indicating cash outflows from operations. Although there is a slight improvement in free cash flow growth, the company struggles to convert net income into positive cash flow, as evidenced by the negative operating cash flow to net income ratio. This poses a risk to liquidity and operational sustainability.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue16.90M17.95M22.22M11.67M6.87M
Gross Profit6.98M8.82M11.78M5.57M2.52M
EBITDA800.05K2.09M5.68M1.57M-1.81M
Net Income-835.20K600.28K4.44M608.33K-2.68M
Balance Sheet
Total Assets24.54M24.55M22.96M15.48M13.28M
Cash, Cash Equivalents and Short-Term Investments831.06K1.68M3.23M144.88K849.50K
Total Debt7.75M6.44M7.31M7.82M8.44M
Total Liabilities17.83M16.45M15.62M12.84M11.46M
Stockholders Equity6.62M8.00M7.25M2.54M1.73M
Cash Flow
Free Cash Flow-3.37M-594.48K4.57M-292.54K-1.96M
Operating Cash Flow-3.20M-256.31K5.55M-82.77K-1.81M
Investing Cash Flow-169.65K-328.33K-965.82K-209.77K122.77K
Financing Cash Flow2.52M-962.02K-1.50M-412.09K2.37M

CanadaBis Capital Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.03
Negative
100DMA
0.04
Negative
200DMA
0.05
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
29.95
Positive
STOCH
-66.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CANB, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.03, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 29.95 is Positive, neither overbought nor oversold. The STOCH value of -66.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CANB.

CanadaBis Capital Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
55
Neutral
$13.29B17.4210.03%0.93%7.13%-12.93%
45
Neutral
$7.56M-1.83-93.87%-0.74%81.49%
44
Neutral
C$15.39M-2.7915.64%58.47%
41
Neutral
C$3.46M-2.69-11.42%-5.87%-239.53%
38
Underperform
C$3.84M-1.331.60%-213.10%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CANB
CanadaBis Capital
0.03
-0.03
-58.33%
TSE:PCLO
PharmaCielo
0.10
0.00
0.00%
TSE:SPR
Sproutly Canada
0.02
0.00
0.00%
TSE:CDVA
CordovaCann
0.04
>-0.01
-12.50%
IMCC
IM Cannabis Corp
1.44
-0.88
-37.93%

CanadaBis Capital Corporate Events

Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
CanadaBis Posts Positive Operating Cash Flow in Q1 2026 Amid BC Market Disruptions
Neutral
Dec 31, 2025

CanadaBis Capital reported fiscal Q1 2026 results showing gross revenue of $5.7 million and net revenue of $3.3 million, with gross margin improving to 27.0% and positive operating cash flow of $0.4 million, despite a net loss and lower sales versus the prior year. Performance was weighed down by temporary labor disruptions at the British Columbia Liquor Distribution Branch, which the company estimates cost about $0.5 million in lost cannabis sales, but management highlighted benefits from recent cost and labour efficiency measures and a shift to higher-margin products, and underscored continued focus on liquidity by opting to pay upcoming convertible debenture interest in shares rather than cash, a move that preserves cash but dilutes equity holders while supporting balance sheet flexibility.

The most recent analyst rating on (TSE:CANB) stock is a Hold with a C$0.02 price target. To see the full list of analyst forecasts on CanadaBis Capital stock, see the TSE:CANB Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
CanadaBis Capital Proposes Convertible Debenture Price Reduction and Interest Payment in Shares
Positive
Dec 10, 2025

CanadaBis Capital Inc. has announced its proposal to reduce the conversion price of its outstanding Convertible Debentures from $0.10 to $0.075 per Common Share, subject to approval by the TSX Venture Exchange. Additionally, the company plans to pay the upcoming interest on these debentures through the issuance of common shares, rather than cash, to strengthen liquidity and align shareholder interests. These strategic moves are aimed at enhancing the company’s financial foundation and supporting its growth initiatives in the cannabis industry.

Business Operations and StrategyFinancial Disclosures
CanadaBis Capital Reports 2025 Financial Results and Strategic Initiatives
Neutral
Nov 28, 2025

CanadaBis Capital Inc. announced its financial results for the fiscal year ending July 31, 2025, reporting gross revenue of $30.53 million and a gross profit of $7.38 million. Despite challenges in fiscal 2025, the company is focused on strategic initiatives to enhance sales growth and product margins, including securing favorable feedstock pricing agreements and expanding its national presence.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 02, 2026